FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

963211000001105: Lithium carbonate 250mg tablets 100 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
22618301000001111 Lithium carbonate 250mg tablets 100 tablet (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
22618401000001115 Lithium carbonate 250mg tablets 100 tablet en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

5 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Lithium carbonate 250mg tablets 100 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Lithium carbonate 250mg tablets 100 tablet Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Lithium carbonate 250mg tablets 100 tablet Is pack of Product containing precisely lithium carbonate 250 milligram/1 each conventional release oral tablet false Inferred relationship Existential restriction modifier
Lithium carbonate 250mg tablets 100 tablet Has active ingredient Lithium carbonate false Inferred relationship Existential restriction modifier
Lithium carbonate 250mg tablets 100 tablet VMP prescribing status (attribute) Not recommended to prescribe as a VMP false Inferred relationship Existential restriction modifier
Lithium carbonate 250mg tablets 100 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Lithium carbonate 250mg tablets 100 tablet Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Lithium carbonate 250mg tablets 100 tablet Has VMP Product containing precisely lithium carbonate 250 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Lithium carbonate 250mg tablets 100 tablet Has specific active ingredient Lithium carbonate true Inferred relationship Existential restriction modifier
Lithium carbonate 250mg tablets 100 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Lithium carbonate 250mg tablets 100 tablet VMP prescribing status (attribute) VMP not recommended to prescribe - brands not bioequivalent false Inferred relationship Existential restriction modifier
Lithium carbonate 250mg tablets 100 tablet VMP prescribing status (attribute) Caution - AMP level prescribing advised true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Camcolit 250 tablets (Norgine Ltd) 100 tablet Is a True Lithium carbonate 250mg tablets 100 tablet Inferred relationship Existential restriction modifier
Camcolit 250 tablets (Waymade Healthcare Plc) 100 tablet Is a True Lithium carbonate 250mg tablets 100 tablet Inferred relationship Existential restriction modifier
Lithium carbonate 250mg tablets (Essential Pharma Ltd) 100 tablet Is a True Lithium carbonate 250mg tablets 100 tablet Inferred relationship Existential restriction modifier
Lithium carbonate 250mg tablets (Alliance Healthcare (Distribution) Ltd) 100 tablet Is a True Lithium carbonate 250mg tablets 100 tablet Inferred relationship Existential restriction modifier
Lithium carbonate 250mg tablets (A A H Pharmaceuticals Ltd) 100 tablet Is a True Lithium carbonate 250mg tablets 100 tablet Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start